This is the authors' abstract. We don't add key points for this paper.
In 1987, while investigating the iap gene in Escherichia coli, Nakata and colleagues identified "five highly homologous sequences of 29 nucleotides were arranged as direct repeats with 32 nucleotides as spacing."Perplexed by this discovery, the authors stated, "so far, no sequence homologous to these has been found elsewhere in prokaryotes, and the biological significance of these sequences is not known."These few sentences launched a decades-long investigation into the biological mystery of clustered regularly interspaced short palindromic repeats, or CRISPR (Ishino et al., 1987).Since its first identification, CRISPR-an adaptive immune response in prokaryotic organisms to recognize and combat infectious DNA-has been developed into a tool for targeted gene editing in a variety of cells and organisms (Jansen et al., 2002).The utility of CRISPR lies in the easy targeting of virtually any genomic location by a short RNA guide.In its simplest form, the two components that must be expressed in cells to perform genome editing are the Cas9 nuclease and a guide RNA (gRNA; Hille and Charpentier, 2016).Due to this simplicity, high efficiency and multiplex genome editing capabilities, CRISPR-Cas has become a highly relied upon editing tool.As the development of effective, reliable, and customizable in vivo gene editing technologies advanced, so too did genetically encoded tools for visualizing and manipulating cellular function in vivo.Optogenetics and several other transgene technologies-fiber photometry, chemogenetics, and one-photon imaging-emerged in the early 2000s, enabling optical recording or manipulation of specified cell types.While targeted in vivo genetic editing reveals the impact of specific genes on nervous system functions and diseases, tools like optogenetics allow investigation of the functional roles of cells and circuits in behavior.The next logical step in the progression of these technologies was to combine gene editing with transgene expression, facilitating groundbreaking insights into how genes regulate cellular and circuit activity.Currently, however, platforms that combine CRISPR-Cas with cell-specific transgene expression for neuronal visualization or manipulation are inadequate.The large Cas enzyme and limited packaging space of AAVs prevent reliable copackaging of transgenes with Cas, necessitating a two-vector transduction system (Swiech et al., 2015).However, coinjection of AAVs is often inefficient.The recent eNeuro article by Moffa et al. (2024) has addressed this issue by developing a platform that combines Cre-dependent Cas9 mouse lines with Cre-driver lines, enabling cell type-specific Cas9 expression (Platt et al., 2014).Now, a single viral vector containing a targeted gRNA and a transgene of choice can be used to achieve an edited neuronal population that fully overlaps with transgene expression.This platform provides a robust approach to test novel genes for effects on synaptic transmission, circuit activity, morphology, and behavior.To test the utility of a single-vector approach for transgene expression and CRISPR-Cas9 editing, Moffa et al. ( 2024) carefully designed three discrete constructs where either ChRonos, GCaMp8f, or mCherry were inserted into modified viral vectors along with
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Carlee Toddes (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: